Status:
COMPLETED
Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography
Lead Sponsor:
The General Authority for Teaching Hospitals and Institutes
Conditions:
Three Dimension
Digital Tomosynthesis
Eligibility:
FEMALE
30+ years
Brief Summary
This study aimed to compare the supremacy of (3D) tomosynthesis versus (2D) digital mammography in the diagnosis of benign breast lesions in asymptomatic females.
Detailed Description
Most of the breast lesions are benign, but much concern is given to malignant lesions because breast cancer is the most common malignancy in women. Mammography is the only study for screening in asym...
Eligibility Criteria
Inclusion
- \- Women with benign breast lesions.
Exclusion
- Pregnant and lactating female.
- Patients who refuse to fill the consent form.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2025
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT07145892
Start Date
June 1 2024
End Date
May 29 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Authority for Teaching Hospitals and Institutes
Cairo, Egypt